This page covers clinically feasible psoriasis thesis ideas for MD Dermatology candidates, including clinical epidemiology, risk factors, dermoscopy, histopathology, nail and scalp disease, special-site psoriasis, quality of life, metabolic associations, treatment adherence, safety and early treatment response that can usually be completed within one thesis period using patients, clinical assessment and investigations already available in a dermatology department. The emphasis is on psoriasis thesis topics, psoriasis research topics, dermatology psoriasis protocol and dermatology psoriasis synopsis choices that can be converted into a focused protocol or synopsis without making the project dependent on non-routine resources.
Last reviewed and updated: September 2026 · 2026–27 admissions
Clinical, Epidemiological, Phenotypic and Risk-Factor Studies
- Clinical and epidemiological profile of chronic plaque psoriasis and its association with disease severity: a cross-sectional observational study.
- Pattern of age at onset, duration of disease and family history in patients with psoriasis and their association with Psoriasis Area and Severity Index: a cross-sectional analytical study.
- Distribution of clinical morphological variants of psoriasis among patients attending a dermatology outpatient department: a cross-sectional observational study.
- Association of body mass index with clinical severity of chronic plaque psoriasis: a cross-sectional analytical study.
- Association of waist circumference and central obesity with Psoriasis Area and Severity Index in adults with chronic plaque psoriasis: a cross-sectional analytical study.
- Association between smoking status and severity of chronic plaque psoriasis: a cross-sectional analytical study.
- Association between alcohol consumption and clinical severity of psoriasis among adult dermatology patients: a cross-sectional analytical study.
- Frequency and pattern of self-reported precipitating factors in patients with psoriasis and their relationship with disease severity: a cross-sectional observational study.
- Association of psychological stress with severity of chronic plaque psoriasis using a validated stress questionnaire: a cross-sectional analytical study.
- Clinical profile and severity of psoriasis in patients with and without a positive family history: a comparative cross-sectional study.
- Comparative clinical characteristics of early-onset and late-onset psoriasis: a cross-sectional analytical study.
- Association of duration of psoriasis with extent and severity of cutaneous involvement: a cross-sectional analytical study.
- Clinical pattern and severity of scalp involvement in patients with psoriasis: a cross-sectional observational study.
- Frequency and clinical characteristics of palmoplantar involvement in patients with psoriasis: a cross-sectional observational study.
- Clinical profile of inverse psoriasis and its association with obesity and overall disease severity: a cross-sectional analytical study.
- Frequency and pattern of facial involvement in chronic plaque psoriasis and its association with overall disease severity: a cross-sectional analytical study.
- Clinical profile of flexural involvement among patients with psoriasis and its association with body mass index: a cross-sectional analytical study.
- Prevalence and pattern of pruritus in psoriasis and its correlation with Psoriasis Area and Severity Index: a cross-sectional analytical study.
- Association of sleep disturbance with pruritus and severity of psoriasis: a cross-sectional analytical study.
- Pattern of seasonal variation reported by patients with psoriasis and its association with clinical phenotype: a cross-sectional observational study.
- Clinical characteristics of psoriasis in patients with recurrent winter exacerbations compared with those without seasonal exacerbation: a comparative cross-sectional study.
- Frequency of Koebner phenomenon in chronic plaque psoriasis and its association with disease activity and severity: a cross-sectional analytical study.
- Association of recent infections reported by patients with exacerbation of psoriasis: a case-control study.
- Clinical and epidemiological profile of guttate psoriasis in patients attending a tertiary dermatology centre: a cross-sectional observational study.
- Comparison of clinical characteristics and severity between patients with scalp-predominant psoriasis and generalised plaque psoriasis: a comparative cross-sectional study.
- Frequency and pattern of mucosal changes in patients with psoriasis undergoing routine dermatological examination: a cross-sectional observational study.
- Frequency of fissuring, pain and functional limitation in palmoplantar psoriasis and their relationship with clinical severity: a cross-sectional analytical study.
- Association of occupational mechanical exposure with palmoplantar involvement among patients with psoriasis: a case-control study.
- Pattern of psoriasis according to Fitzpatrick skin phototype and its association with clinical severity: a cross-sectional analytical study.
- Comparison of clinical severity of psoriasis between patients with normal weight, overweight and obesity: a comparative cross-sectional study.
- Association between sedentary lifestyle and severity of chronic plaque psoriasis: a cross-sectional analytical study.
- Relationship of dietary patterns reported by patients with chronic plaque psoriasis to disease severity: a cross-sectional analytical study.
- Frequency and pattern of treatment interruption among patients with psoriasis and factors associated with interruption: a cross-sectional analytical study.
- Prevalence and determinants of self-medication among patients with psoriasis attending dermatology services: a cross-sectional analytical study.
- Pattern of topical corticosteroid misuse among patients with psoriasis and its association with cutaneous adverse effects: a cross-sectional observational study.
- Comparison of clinical severity and cutaneous adverse effects in patients with and without unsupervised topical corticosteroid use for psoriasis: a comparative cross-sectional study.
- Sources of treatment advice and patterns of non-prescription therapy use among patients with psoriasis: a cross-sectional observational study.
- Clinical profile of treatment-naive psoriasis compared with previously treated psoriasis: a comparative cross-sectional study.
- Association of delayed dermatology consultation with disease severity and extent in patients with psoriasis: a cross-sectional analytical study.
- Factors associated with severe chronic plaque psoriasis among adults attending a dermatology outpatient department: a case-control study.
Dermoscopy, Histopathology and Diagnostic Correlation
- Dermoscopic patterns of chronic plaque psoriasis and their correlation with Psoriasis Area and Severity Index: a cross-sectional analytical study.
- Correlation of dermoscopic vascular patterns with clinical severity in chronic plaque psoriasis: a cross-sectional analytical study.
- Correlation of dermoscopic scaling patterns with clinical characteristics of plaque psoriasis: a cross-sectional analytical study.
- Dermoscopic features of active and stable psoriatic plaques: a comparative cross-sectional study.
- Dermoscopic characteristics of psoriasis at different anatomical sites: a cross-sectional observational study.
- Comparison of dermoscopic findings in scalp psoriasis and seborrheic dermatitis: a comparative cross-sectional study.
- Diagnostic accuracy of dermoscopy in differentiating scalp psoriasis from seborrheic dermatitis using clinical diagnosis as the reference standard: a diagnostic accuracy study.
- Comparison of dermoscopic findings in palmoplantar psoriasis and chronic hand or foot eczema: a comparative cross-sectional study.
- Diagnostic accuracy of dermoscopy in differentiating palmoplantar psoriasis from chronic palmoplantar eczema using clinicopathological diagnosis as the reference standard: a diagnostic accuracy study.
- Dermoscopic patterns of inverse psoriasis and their correlation with clinical findings: a cross-sectional observational study.
- Dermoscopic characteristics of facial psoriasis and their correlation with clinical morphology: a cross-sectional observational study.
- Comparison of dermoscopic features of psoriasis and lichen planus in clinically equivocal papulosquamous lesions: a comparative cross-sectional study.
- Diagnostic accuracy of dermoscopy for psoriasis in clinically equivocal papulosquamous lesions using histopathology where clinically indicated as the reference standard: a diagnostic accuracy study.
- Correlation between dermoscopic findings and routine histopathological features in psoriasis among patients undergoing clinically indicated biopsy: a cross-sectional analytical study.
- Association of regularly distributed dotted vessels on dermoscopy with histopathological capillary dilatation in psoriasis: a correlation study.
- Association of dermoscopic white scales with histopathological hyperkeratosis and parakeratosis in psoriatic plaques: a correlation study.
- Association of dermoscopic background colour with epidermal and inflammatory histopathological changes in psoriasis: a correlation study.
- Comparison of dermoscopic features in untreated and previously treated chronic plaque psoriasis: a comparative cross-sectional study.
- Dermoscopic indicators of recent topical corticosteroid use in psoriatic plaques: a cross-sectional observational study.
- Comparison of dermoscopic vascular morphology in mild and moderate-to-severe plaque psoriasis: a comparative cross-sectional study.
- Dermoscopic features of psoriatic plaques with and without Koebner phenomenon: a comparative cross-sectional study.
- Correlation of plaque thickness on clinical examination with dermoscopic vascular visibility in psoriasis: a cross-sectional analytical study.
- Relationship between erythema severity and dermoscopic vascular density in plaque psoriasis: a correlation study.
- Dermoscopic pattern of resolving psoriatic plaques during routine treatment: a prospective observational study with short-term assessment.
- Early dermoscopic changes in chronic plaque psoriasis after four weeks of routine topical treatment: a prospective observational study.
- Correlation between early dermoscopic changes and reduction in Psoriasis Area and Severity Index after eight weeks of routine treatment: a prospective observational study.
- Comparison of clinical and dermoscopic assessment of erythema and scaling in chronic plaque psoriasis: a cross-sectional comparative study.
- Dermoscopic findings in scalp psoriasis and their association with scalp disease severity: a cross-sectional analytical study.
- Dermoscopic features of palmoplantar psoriasis and their association with fissuring and functional symptoms: a cross-sectional analytical study.
- Dermoscopic patterns in psoriasis involving flexural areas and their correlation with clinical morphology: a cross-sectional observational study.
- Dermoscopic findings of genital psoriasis in patients undergoing clinically indicated genital examination and their correlation with clinical morphology: a cross-sectional observational study.
- Comparison of dermoscopic patterns of chronic plaque psoriasis in sun-exposed and non-sun-exposed sites: a within-patient comparative cross-sectional study.
- Intra-patient comparison of dermoscopic findings in newly developed and longstanding psoriatic plaques: a comparative cross-sectional study.
- Correlation of dermoscopic vascular patterns with plaque duration in chronic plaque psoriasis: a cross-sectional analytical study.
- Histopathological spectrum of clinically diagnosed psoriasis in patients undergoing clinically indicated biopsy: a retrospective observational study.
- Clinicopathological concordance in psoriasis among patients undergoing routine diagnostic biopsy: a retrospective observational study.
- Frequency of classical histopathological features of psoriasis and their association with clinical phenotype: a cross-sectional analytical study.
- Comparison of clinical, dermoscopic and histopathological findings in chronic plaque psoriasis with diagnostically difficult papulosquamous disorders: a comparative cross-sectional study.
- Diagnostic contribution of dermoscopy before clinically indicated biopsy in suspected psoriasis: a prospective observational study.
- Agreement between clinical diagnosis and dermoscopic diagnosis of psoriasis in patients presenting with papulosquamous lesions: a cross-sectional analytical study.
Nail, Scalp, Joint-Symptom and Special-Site Psoriasis
- Prevalence and clinical pattern of nail involvement in patients with psoriasis: a cross-sectional observational study.
- Correlation of Nail Psoriasis Severity Index with Psoriasis Area and Severity Index in patients with psoriasis: a cross-sectional analytical study.
- Association between nail psoriasis and duration of cutaneous psoriasis: a cross-sectional analytical study.
- Comparison of disease severity in psoriasis patients with and without nail involvement: a comparative cross-sectional study.
- Onychoscopic patterns of nail psoriasis and their correlation with Nail Psoriasis Severity Index: a cross-sectional analytical study.
- Correlation of onychoscopic nail matrix findings with clinical nail matrix changes in psoriasis: a cross-sectional analytical study.
- Correlation of onychoscopic nail bed findings with clinical nail bed changes in psoriasis: a cross-sectional analytical study.
- Diagnostic accuracy of onychoscopy in differentiating nail psoriasis from onychomycosis using potassium hydroxide examination of clinically indicated nail clippings as the reference standard: a diagnostic accuracy study.
- Comparison of onychoscopic findings in nail psoriasis and onychomycosis: a comparative cross-sectional study.
- Frequency of concomitant onychomycosis in patients with nail psoriasis using potassium hydroxide examination and fungal culture when clinically indicated: a cross-sectional observational study.
- Clinical predictors of positive fungal examination among patients with psoriatic nail dystrophy: a cross-sectional analytical study.
- Relationship between nail psoriasis severity and impairment in dermatology-related quality of life: a cross-sectional analytical study.
- Association of nail psoriasis with self-reported inflammatory joint symptoms in patients with psoriasis: a cross-sectional analytical study.
- Frequency of musculoskeletal symptoms suggestive of psoriatic arthritis among patients with cutaneous psoriasis using a validated screening questionnaire: a cross-sectional observational study.
- Clinical predictors of positive psoriatic arthritis screening among patients attending a dermatology clinic with psoriasis: a cross-sectional analytical study.
- Comparison of cutaneous psoriasis severity in patients with and without inflammatory joint symptoms: a comparative cross-sectional study.
- Association of scalp psoriasis with inflammatory joint symptoms among patients with psoriasis: a cross-sectional analytical study.
- Association of nail psoriasis with inflammatory joint symptoms after adjustment for cutaneous disease severity: a cross-sectional analytical study.
- Frequency and clinical pattern of scalp psoriasis among adults with chronic plaque psoriasis: a cross-sectional observational study.
- Correlation between scalp psoriasis severity and overall Psoriasis Area and Severity Index: a cross-sectional analytical study.
- Association of scalp involvement with pruritus intensity in psoriasis: a cross-sectional analytical study.
- Relationship between scalp psoriasis severity and Dermatology Life Quality Index: a cross-sectional analytical study.
- Comparison of quality-of-life impairment in psoriasis patients with and without scalp involvement: a comparative cross-sectional study.
- Clinical and dermoscopic profile of isolated or predominantly scalp psoriasis: a cross-sectional observational study.
- Clinical characteristics of palmoplantar psoriasis and their relationship with overall psoriasis severity: a cross-sectional analytical study.
- Relationship between palmoplantar psoriasis severity and functional impairment in daily activities: a cross-sectional analytical study.
- Comparison of Dermatology Life Quality Index in patients with palmoplantar psoriasis and plaque psoriasis without palmoplantar involvement: a comparative cross-sectional study.
- Clinical and dermoscopic profile of palmoplantar psoriasis with emphasis on fissuring and hyperkeratosis: a cross-sectional observational study.
- Clinical profile of facial psoriasis and its relationship with overall psoriasis severity: a cross-sectional analytical study.
- Quality-of-life impairment associated with facial involvement in chronic plaque psoriasis: a cross-sectional analytical study.
- Comparison of disease severity and quality of life in psoriasis patients with and without facial involvement: a comparative cross-sectional study.
- Frequency and clinical characteristics of flexural psoriasis among patients with chronic plaque psoriasis: a cross-sectional observational study.
- Association of flexural psoriasis with obesity and central adiposity: a cross-sectional analytical study.
- Clinical profile and quality-of-life impact of genital psoriasis in patients undergoing clinically warranted examination: a cross-sectional observational study.
- Association of genital involvement with overall disease severity in psoriasis: a cross-sectional analytical study.
- Comparison of Dermatology Life Quality Index among psoriasis patients with special-site involvement and those without special-site involvement: a comparative cross-sectional study.
- Cumulative burden of scalp, nail, palmoplantar and facial involvement and its association with Dermatology Life Quality Index in psoriasis: a cross-sectional analytical study.
- Association between number of special sites involved and Psoriasis Area and Severity Index in chronic plaque psoriasis: a cross-sectional analytical study.
- Clinical predictors of nail involvement in patients with chronic plaque psoriasis: a case-control study.
- Clinical predictors of special-site involvement among patients with psoriasis: a cross-sectional analytical study.
Severity, Quality of Life, Metabolic and Routine Laboratory Associations
- Correlation between Psoriasis Area and Severity Index and Dermatology Life Quality Index in chronic plaque psoriasis: a cross-sectional analytical study.
- Comparison of Dermatology Life Quality Index across mild, moderate and severe psoriasis categories: a comparative cross-sectional study.
- Association of body surface area involvement with Dermatology Life Quality Index in psoriasis: a cross-sectional analytical study.
- Relationship between pruritus severity and Dermatology Life Quality Index in chronic plaque psoriasis: a cross-sectional analytical study.
- Association of visible-site involvement with quality-of-life impairment in patients with psoriasis: a cross-sectional analytical study.
- Determinants of severe quality-of-life impairment among patients with chronic plaque psoriasis: a cross-sectional analytical study.
- Relationship between duration of psoriasis and Dermatology Life Quality Index: a cross-sectional analytical study.
- Comparison of quality-of-life impairment between early-onset and late-onset psoriasis: a comparative cross-sectional study.
- Association of treatment-related financial burden with Dermatology Life Quality Index among patients with psoriasis: a cross-sectional analytical study.
- Relationship between sleep disturbance and Dermatology Life Quality Index in patients with chronic plaque psoriasis: a cross-sectional analytical study.
- Prevalence of overweight, obesity and central obesity among adults with psoriasis and their association with disease severity: a cross-sectional analytical study.
- Prevalence of metabolic syndrome among patients with chronic plaque psoriasis and its association with Psoriasis Area and Severity Index: a cross-sectional analytical study.
- Comparison of frequency of metabolic syndrome in patients with psoriasis and age- and sex-matched dermatology controls: a case-control study.
- Association of individual metabolic syndrome components with severity of chronic plaque psoriasis: a cross-sectional analytical study.
- Relationship between fasting blood glucose levels and severity of psoriasis among patients undergoing routine metabolic evaluation: a cross-sectional analytical study.
- Association of glycated haemoglobin with psoriasis severity among patients in whom testing is clinically indicated: a cross-sectional analytical study.
- Relationship between serum triglyceride levels and Psoriasis Area and Severity Index in chronic plaque psoriasis: a cross-sectional analytical study.
- Association of high-density lipoprotein cholesterol levels with clinical severity of psoriasis: a cross-sectional analytical study.
- Comparison of lipid profile abnormalities between patients with psoriasis and dermatology controls: a case-control study.
- Association of dyslipidaemia with extent of psoriasis measured by body surface area: a cross-sectional analytical study.
- Relationship between body mass index and Dermatology Life Quality Index in chronic plaque psoriasis: a cross-sectional analytical study.
- Association of central obesity with special-site involvement in psoriasis: a cross-sectional analytical study.
- Comparison of clinical severity and quality-of-life impairment in psoriasis patients with and without metabolic syndrome: a comparative cross-sectional study.
- Association of blood pressure abnormalities with psoriasis severity among adults undergoing routine clinical assessment: a cross-sectional analytical study.
- Frequency of previously diagnosed diabetes mellitus and hypertension among patients with psoriasis and their relationship with disease severity: a cross-sectional observational study.
- Association of serum uric acid levels with severity of psoriasis among patients tested as part of routine clinical care: a cross-sectional analytical study.
- Correlation between routine liver enzyme abnormalities and psoriasis severity among patients undergoing clinically indicated biochemical evaluation: a cross-sectional analytical study.
- Pattern of routine haematological abnormalities in patients with chronic plaque psoriasis and their association with disease severity: a cross-sectional analytical study.
- Association of haemoglobin level with psoriasis severity and quality of life: a cross-sectional analytical study.
- Relationship between total leucocyte count and clinical severity of psoriasis among patients with routinely available complete blood counts: a cross-sectional analytical study.
- Relationship between platelet count and severity of chronic plaque psoriasis using routine complete blood count data: a cross-sectional analytical study.
- Association of routinely available neutrophil-to-lymphocyte ratio with Psoriasis Area and Severity Index: a cross-sectional analytical study.
- Association of routinely available platelet-to-lymphocyte ratio with clinical severity of psoriasis: a cross-sectional analytical study.
- Comparison of neutrophil-to-lymphocyte ratio in mild and moderate-to-severe psoriasis: a comparative cross-sectional study.
- Association of thyroid dysfunction with psoriasis severity among patients undergoing clinically indicated thyroid testing: a cross-sectional analytical study.
- Comparison of frequency of known thyroid disorders in psoriasis patients and dermatology controls: a case-control study.
- Association of obesity, hypertension, diabetes mellitus and dyslipidaemia burden with psoriasis severity: a cross-sectional analytical study.
- Relationship between number of metabolic comorbidities and Dermatology Life Quality Index in chronic plaque psoriasis: a cross-sectional analytical study.
- Clinical predictors of metabolic syndrome among adults with chronic plaque psoriasis: a cross-sectional analytical study.
- Comparison of demographic, clinical and metabolic characteristics of psoriasis patients with mild versus severe disease: a comparative cross-sectional study.
Treatment Patterns, Adherence, Safety and Short-Term Response
- Treatment patterns among patients with chronic plaque psoriasis attending a tertiary dermatology centre: a cross-sectional observational study.
- Adherence to prescribed topical therapy in chronic plaque psoriasis and factors associated with poor adherence: a cross-sectional analytical study.
- Association between treatment adherence and current psoriasis severity among patients receiving topical therapy: a cross-sectional analytical study.
- Patient-reported barriers to adherence with topical treatment for psoriasis: a cross-sectional observational study.
- Relationship between knowledge of psoriasis and adherence to prescribed treatment: a cross-sectional analytical study.
- Association of treatment satisfaction with Dermatology Life Quality Index in patients with chronic plaque psoriasis: a cross-sectional analytical study.
- Pattern of complementary and alternative medicine use among patients with psoriasis and its association with treatment adherence: a cross-sectional analytical study.
- Frequency and determinants of unsupervised treatment modification among patients with psoriasis: a cross-sectional analytical study.
- Pattern and adverse effects of topical corticosteroid misuse in chronic plaque psoriasis: a cross-sectional observational study.
- Comparison of cutaneous adverse effects between psoriasis patients with supervised and unsupervised topical corticosteroid use: a comparative cross-sectional study.
- Clinical predictors of unsupervised potent topical corticosteroid use among patients with psoriasis: a case-control study.
- Frequency of fixed-dose corticosteroid-containing topical combination use among patients with psoriasis and associated clinical adverse effects: a cross-sectional observational study.
- Association of prior self-medication with current clinical severity in chronic plaque psoriasis: a cross-sectional analytical study.
- Early change in Psoriasis Area and Severity Index after four weeks of routine topical treatment in chronic plaque psoriasis: a prospective observational study.
- Early change in Psoriasis Area and Severity Index after eight weeks of routine treatment and its clinical predictors: a prospective observational study.
- Twelve-week clinical response to routinely prescribed treatment in chronic plaque psoriasis and baseline predictors of response: a prospective observational study.
- Association of baseline body mass index with twelve-week improvement in Psoriasis Area and Severity Index during routine treatment: a prospective observational study.
- Association of baseline disease duration with early clinical response to routine treatment in chronic plaque psoriasis: a prospective observational study.
- Relationship between baseline Psoriasis Area and Severity Index and percentage improvement at eight weeks of routine therapy: a prospective observational study.
- Early improvement in Dermatology Life Quality Index following eight weeks of routine treatment for chronic plaque psoriasis: a prospective observational study.
- Correlation between reduction in Psoriasis Area and Severity Index and improvement in Dermatology Life Quality Index after twelve weeks of routine treatment: a prospective observational study.
- Clinical and dermoscopic changes in psoriatic plaques after eight weeks of routine topical therapy: a prospective observational study.
- Association of baseline dermoscopic vascular pattern with early response to routine topical therapy in chronic plaque psoriasis: a prospective observational study.
- Comparison of short-term clinical response among patients receiving different routinely prescribed topical treatment regimens for mild plaque psoriasis: an observational comparative study.
- Comparison of early clinical response in patients receiving topical corticosteroid alone and topical corticosteroid with vitamin D analogue as part of routine care: an observational comparative study.
- Comparison of tolerability and early clinical response of routinely prescribed coal tar-based and non-coal tar topical regimens in localised plaque psoriasis: an observational comparative study.
- Short-term response of scalp psoriasis to routinely prescribed topical treatment and factors associated with poor response: a prospective observational study.
- Early clinical response of palmoplantar psoriasis to routine treatment and baseline predictors of improvement: a prospective observational study.
- Short-term change in Nail Psoriasis Severity Index among patients receiving clinically indicated routine therapy for nail psoriasis: a prospective observational study.
- Association between treatment adherence and eight-week improvement in Psoriasis Area and Severity Index: a prospective observational study.
- Association of topical treatment quantity and frequency of application with early clinical response in localised plaque psoriasis: a prospective observational study.
- Frequency and pattern of adverse effects during the first twelve weeks of routinely prescribed systemic treatment for psoriasis: a prospective observational study.
- Pattern of routine laboratory abnormalities during early systemic treatment of psoriasis using clinically indicated monitoring records: a retrospective observational study.
- Comparison of early adverse-effect profiles of commonly used systemic therapies for psoriasis in routine dermatology practice: a retrospective comparative study.
- Clinical characteristics associated with selection of systemic therapy in moderate-to-severe psoriasis: a retrospective observational study.
- Early clinical response to methotrexate prescribed as routine care for moderate-to-severe chronic plaque psoriasis: a prospective observational study.
- Baseline clinical predictors of twelve-week response to methotrexate in chronic plaque psoriasis: a prospective observational study.
- Association of body mass index with early response to methotrexate in patients with moderate-to-severe psoriasis: a prospective observational study.
- Comparison of Dermatology Life Quality Index before and after twelve weeks of routinely prescribed systemic therapy for psoriasis: a prospective observational study.
- Association of baseline adherence-related factors with short-term treatment response in chronic plaque psoriasis: a prospective observational study.
Not the dermatology subspeciality you need? Psoriasis is one section of our full dermatology collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.
Browse all Dermatology Thesis Topics →
📌 Updated for 2026–2027 MD Dermatology Psoriasis admissions
The proposed designs were reviewed for feasibility in routine dermatology departments, with particular attention to PASI, special-site disease, dermoscopy, metabolic associations, treatment adherence and short-term outcomes.
- Most topics can be completed with clinical examination, PASI, body surface area, DLQI, NAPSI, dermoscopy, onychoscopy and routine metabolic or laboratory investigations already used in clinical care.
- Advanced biomarkers, molecular testing, repeated research-only biopsy and expensive imaging are generally not required for a feasible residency project.
- Publication potential is strongest when the primary severity measure, special-site definition, treatment exposure and follow-up outcome are fixed before enrolment.
Generate a protocol from any topic above
Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:
- Introduction / Synopsis
- Research Question
- Aim of the Study
- Primary Objective
- Secondary Objectives
- Materials and Methods
- Inclusion Criteria
- Exclusion Criteria
- Sample Size Calculation
- Methodology
- Statistical Analysis
- Ethical Considerations
- Review of Literature
- References
- Gantt Chart / Study Timeline
- Patient Information Sheet
- Consent Form
- Data Collection Form
Already have your thesis title?
Generate the full psoriasis protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.
Generate your protocol
Alongside psoriasis protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.
Enquire on WhatsApp →
Psoriasis research outside India
The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the psoriasis research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.
Board and residency programmes — country by country
Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the psoriasis research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.
United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a psoriasis research protocol for their programme and submit it for institutional review board approval before any data are collected.
Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A psoriasis IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.
Bahrain — NHRA. Trainees turning psoriasis research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.
Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the psoriasis research proposal is the document assessed at the start of it.
Kuwait — KIMS. A psoriasis study protocol goes to the institutional committee for approval before the project begins.
Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the psoriasis proposal follows the same structure throughout.
Postgraduate degrees — Malaysia, the Gulf and beyond
Malaysia — MMed, the National Medical Research Register and MREC. A psoriasis dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.
PhD and Master's candidates elsewhere. University programmes generally require a full psoriasis research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.
PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.
Enquire about a psoriasis PhD or MMed proposal →
🔥 Trending research areas in Psoriasis for 2026–27
- Special-site psoriasis is increasingly important because nail, scalp, palmoplantar, facial and genital disease can cause disproportionate functional and quality-of-life burden despite a modest total PASI.
- Metabolic comorbidity research remains clinically relevant because obesity, central adiposity, dyslipidaemia, diabetes and hypertension frequently intersect with psoriasis severity and treatment choice.
- Dermoscopy is useful for difficult papulosquamous differentials and short-term treatment monitoring when image acquisition and the diagnostic reference standard are clearly defined.
- Real-world adherence and treatment-response studies remain high-yield because topical treatment interruption, unsupervised corticosteroid use and non-random selection of systemic therapy strongly influence observed outcomes.
Protocol and synopsis guidance
What a psoriasis protocol must contain
A psoriasis protocol should define the clinical phenotype being studied rather than treating all psoriasis as one uniform condition. Chronic plaque, guttate, inverse, scalp-predominant, palmoplantar, nail, facial, flexural and genital disease may require different outcome measures.
Severity measurement: PASI, body surface area, NAPSI, pruritus scores, special-site scores and DLQI measure different dimensions. The protocol should state which is primary, who performs the assessment and whether the same observer will repeat measurements at follow-up.
Dermoscopy and histopathology: If dermoscopic patterns are correlated with histopathological findings, the study should distinguish correlation from diagnostic accuracy. Clinically difficult papulosquamous lesions require a predefined reference standard, and selective biopsy of only atypical cases can introduce verification bias.
Treatment research: Routine treatment choice is influenced by baseline severity, site, comorbidity, previous therapy and clinician preference. Observational comparisons should therefore report comparative outcomes rather than imply randomised efficacy, and should record adherence, treatment changes and rescue therapy.
Psoriasis synopsis versus psoriasis protocol
A psoriasis synopsis gives the academic committee the research question, rationale, objectives, design, broad methods, sample size, statistical approach and ethics in concise form. It should demonstrate that the project is feasible with the available case-load, follow-up and routine investigations.
The full protocol must define how psoriasis phenotype, PASI, body surface area, DLQI, NAPSI and special-site involvement are measured. It should also specify dermoscopic methods, treatment exposure, adherence assessment, prior topical corticosteroid use, laboratory monitoring and the permitted follow-up window.
For comparative or diagnostic studies, the protocol should explain how confounding and reference-standard problems will be handled. A study comparing routine therapies without accounting for baseline severity or treatment selection can produce a misleading treatment effect even when the synopsis appears methodologically sound.
Sample size and statistical analysis
Sample size should be driven by the primary objective. Prevalence or profile studies need an expected proportion and precision; analytical studies need an anticipated association; case-control studies need an expected exposure difference; and prospective response studies need an expected change in the predefined clinical outcome.
PASI, DLQI and other scores should be analysed according to their distribution and measurement properties. Correlation between PASI and DLQI does not mean that the two measures are interchangeable. Agreement between clinical and dermoscopic diagnosis requires agreement statistics, whereas diagnostic accuracy requires an independent reference standard.
Repeated PASI, NAPSI, pruritus or DLQI assessments require paired or longitudinal analysis. Multivariable models should remain realistic for the available sample and should account for clinically important confounders such as age, obesity, metabolic comorbidity, baseline severity, prior treatment and adherence when relevant to the question.
Frequently Asked Questions – Psoriasis Thesis Topics (2026–27)
1. How should I choose a feasible psoriasis thesis topic for 2026–2027 MD Dermatology admissions?
Choose a question that matches the department's psoriasis case-load and routine assessment pathway. Feasible projects commonly use clinical examination, PASI, body surface area, DLQI, NAPSI, dermoscopy, onychoscopy, routine laboratory investigations and short-term treatment follow-up. A strong thesis should have one clearly defined primary outcome and should avoid depending on expensive biomarkers, research-only investigations or follow-up that cannot be completed within one thesis period.
2. Which study designs are suitable for a psoriasis thesis?
Cross-sectional observational and analytical studies are suitable for clinical profile, risk factors, special-site involvement, quality of life, metabolic associations and dermoscopic findings. Comparative cross-sectional designs work well for phenotypic subgroups or special-site disease. Case-control designs are useful for metabolic syndrome, severe disease or specific clinical predictors. Prospective observational studies can assess early clinical response, adherence, adverse effects and dermoscopic change during routine treatment.
3. What should I settle with my guide before finalising a psoriasis thesis protocol?
Fix the psoriasis phenotype, inclusion criteria, primary severity measure, special-site definitions, treatment exposure, follow-up interval and analysis plan before recruitment. The protocol should state whether PASI, body surface area, NAPSI, a scalp or palmoplantar score, pruritus score or DLQI is the primary outcome. It should also define how prior treatment, topical corticosteroid misuse and treatment adherence will be recorded.
4. How should special-site psoriasis be handled in a thesis?
Scalp, nail, palmoplantar, facial, flexural and genital psoriasis can cause substantial morbidity despite a relatively modest PASI because PASI is weighted towards overall skin extent. These sites should therefore be assessed with site-specific clinical measures or clearly defined symptom and functional outcomes where appropriate. A protocol should avoid concluding that special-site disease is mild solely because total PASI is low.
5. What is the difference between a psoriasis synopsis and a psoriasis protocol?
The synopsis is the concise academic submission that summarises the question, rationale, objectives, design, sample size, broad methods, analysis and ethics. The full psoriasis protocol is the operational document and should specify phenotype definitions, PASI or other severity scoring, special-site assessment, dermoscopic acquisition, treatment exposure, adherence measurement, laboratory monitoring, follow-up windows and statistical methods in enough detail for another investigator to reproduce the study.
6. What ethical issues should a psoriasis thesis address?
For children, guardian consent and child assent from about seven years should be addressed according to institutional policy. Record-based work may seek a waiver of consent where permitted. No additional biopsy, blood sampling or treatment should be added solely for research unless specifically justified and approved, and any research-only venepuncture should state a blood volume limit. Separate consent should cover identifiable clinical photographs or video, including sensitive sites. The protocol should also define escalation for suspected psoriatic arthritis, severe erythrodermic or pustular disease, significant treatment toxicity, infection or clinically important metabolic abnormalities found during routine care.
7. What is the sharpest methodological problem in psoriasis research?
The sharpest problem is treating PASI as a complete measure of disease burden and then using it interchangeably with body surface area, DLQI or special-site severity. PASI measures extent and severity of cutaneous disease but can under-represent nail, scalp, palmoplantar, facial or genital morbidity. The protocol should name one primary outcome and keep disease extent, site-specific severity, symptoms and quality of life analytically distinct. In treatment studies, baseline severity and treatment selection must also be considered because non-random treatment allocation creates confounding by indication.
8. Can a psoriasis topic be adapted for PhD, Saudi Board, Arab Board or Gulf research requirements?
Yes. An MD synopsis usually addresses a focused clinical question that can be completed during residency, whereas a PhD research proposal generally requires a broader conceptual framework, deeper methodological justification and a larger programme of work. Board pathways may also require a separate research project, including SCFHS and Saudi Board requirements, the Arab Board of Health Specializations, and research components linked to DHP, DHA, DOH and MOHAP training programmes. The core psoriasis question can often be retained, but governance, sample size, follow-up and expected outputs should be adapted to the relevant institution or board.
9. When should I register my psoriasis thesis study?
Registration and institutional approvals should be completed before prospective recruitment or study-specific data collection begins. The final protocol, phenotype definition, severity score, treatment exposure, laboratory monitoring and statistical plan should be settled first so that the registered study matches the work actually performed. Retrospective studies should clarify ethics approval and data-access requirements before extracting identifiable clinical records or images.
Found a topic that fits your department?
Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.
Generate your protocol
